Voya Investment Management LLC Cuts Position in Humana Inc. (NYSE:HUM)

Voya Investment Management LLC lowered its stake in shares of Humana Inc. (NYSE:HUM) by 30.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 41,969 shares of the insurance provider’s stock after selling 18,019 shares during the period. Voya Investment Management LLC’s holdings in Humana were worth $10,648,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Dodge & Cox boosted its stake in shares of Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock worth $2,587,345,000 after acquiring an additional 5,264,045 shares in the last quarter. Vanguard Group Inc. boosted its position in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares in the last quarter. Norges Bank acquired a new stake in Humana in the fourth quarter valued at $416,202,000. Pzena Investment Management LLC grew its holdings in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the last quarter. Finally, Boston Partners increased its position in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after buying an additional 893,637 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Truist Financial increased their price objective on shares of Humana from $290.00 to $325.00 and gave the company a “hold” rating in a research note on Friday, April 11th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Mizuho raised their price target on Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Finally, Guggenheim assumed coverage on Humana in a research report on Wednesday, April 9th. They issued a “buy” rating and a $326.00 price objective on the stock. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $284.90.

Humana Stock Down 0.5 %

HUM opened at $263.08 on Tuesday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The firm has a 50 day moving average price of $266.31 and a 200 day moving average price of $270.84. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $31.75 billion, a PE ratio of 26.44, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. Humana’s payout ratio is currently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.